We are live on ! Find out more
CBPO

China Biologic Products Holdings, Inc.
CBPO

Delisted

CBPO was delisted on the 20th of April, 2021.

Back to rankings

0 hedge funds and large institutions have $0 invested in China Biologic Products Holdings, Inc. in 2021 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 84 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 86 → 0 (-86)

100% less funds holding in top 10

Funds holding in top 10: 5 → 0 (-5)

100% less capital invested

Capital invested by funds: $1.74B → $0 (-$1.74B)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 84

Holders
–
Holders Change
-86
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
-5
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
84
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
HA
HHLR Advisors
Cayman Islands
-$351M
2
Temasek Holdings
Temasek Holdings
Singapore
-$147M
3
PCM
Pentwater Capital Management
Florida
-$140M
4
AC
Athos Capital
Hong Kong
-$110M
5
Bank of America
Bank of America
North Carolina
-$99.3M
Name Holding Trade Value Shares
Change 		Change in
Stake
Geode Capital Management
26
Geode Capital Management
Massachusetts
– -$8.13M -68,699 Closed
Legal & General Group
27
Legal & General Group
United Kingdom
– -$7.29M -61,603 Closed
California Public Employees Retirement System
28
California Public Employees Retirement System
California
– -$5.84M -49,330 Closed
Mirae Asset Global Investments
29
Mirae Asset Global Investments
South Korea
– -$5.76M -48,615 Closed
Allianz Asset Management
30
Allianz Asset Management
Germany
– -$5.36M -45,300 Closed
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
31
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Ontario, Canada
– -$4.95M -41,800 Closed
Voloridge Investment Management
32
Voloridge Investment Management
Florida
– -$4.08M -34,421 Closed
Man Group
33
Man Group
United Kingdom
– -$3.66M -30,897 Closed
Two Sigma Investments
34
Two Sigma Investments
New York
– -$3.57M -30,162 Closed
Charles Schwab
35
Charles Schwab
California
– -$3.41M -28,796 Closed
D.E. Shaw & Co
36
D.E. Shaw & Co
New York
– -$2.57M -21,714 Closed
Invesco
37
Invesco
Georgia
– -$2.08M -17,561 Closed
SFI
38
Susquehanna Fundamental Investments
Pennsylvania
– -$2.04M -17,217 Closed
Northern Trust
39
Northern Trust
Illinois
– -$2.01M -16,955 Closed
Walleye Capital
40
Walleye Capital
New York
– -$2K -16,870 Closed
Two Sigma Advisers
41
Two Sigma Advisers
New York
– -$1.85M -15,600 Closed
CL
42
CSS LLC
Illinois
– -$1.78M -15,009 Closed
PPA
43
Parametric Portfolio Associates
Washington
– -$1.76M -14,851 Closed
DLPIC
44
Davide Leone & Partners Investment Company
United Kingdom
– -$1.67M -14,088 Closed
Morgan Stanley
45
Morgan Stanley
New York
– -$1.55M -13,086 Closed
Canada Pension Plan Investment Board
46
Canada Pension Plan Investment Board
Ontario, Canada
– -$1.54M -13,010 Closed
DekaBank Deutsche Girozentrale
47
DekaBank Deutsche Girozentrale
Germany
– -$1.48M -12,690 Closed
Bank of New York Mellon
48
Bank of New York Mellon
New York
– -$1.5M -12,636 Closed
FL
49
Fort LP
Maryland
– -$1.19M -10,055 Closed
Barclays
50
Barclays
United Kingdom
– -$1.17M -9,892 Closed
1
2
3 4

CBPO Hedge Fund Activity: Q2 2021 in Review

0 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in China Biologic Products Holdings, Inc. (CBPO) for Q2 2021, worth a combined $0 — down 100% from $1.74B a quarter earlier.

Sellers outnumbered buyers: 84 funds closed out of CBPO and 0 opened new positions — a net loss of 84 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was HHLR Advisors, exiting entirely with an estimated $351M sold.

  • 0 institutional investors held China Biologic Products Holdings, Inc. (CBPO) as of Q2 2021, down from 86 in Q1 2021.
  • Funds reported $0 of China Biologic Products Holdings, Inc. stock for Q2 2021, down 100% quarter-over-quarter.
  • 0 funds opened new China Biologic Products Holdings, Inc. positions in Q2 2021 and 84 closed out, a net change of -84 holders.
  • The largest China Biologic Products Holdings, Inc. seller in Q2 2021 was HHLR Advisors, an estimated $351M sold.

Based on aggregated 13F filings for Q2 2021.